Antihypertensive treatment and renal protection: Is there a J-curve relationship? - PubMed (original) (raw)

Review

. 2018 Nov;20(11):1560-1574.

doi: 10.1111/jch.13396. Epub 2018 Sep 28.

Affiliations

Review

Antihypertensive treatment and renal protection: Is there a J-curve relationship?

Francesca Viazzi et al. J Clin Hypertens (Greenwich). 2018 Nov.

Abstract

A bidirectional relationship between hypertension and kidney disease, with one exacerbating the effect of the other, is well established. Elevated blood pressure (BP) is a well-recognized, modifiable risk factor for cardiovascular (CV) disease as well as for development and progression of chronic kidney disease and, therefore, the identification of optimal BP target is a key issue in the management of renal patients. Recent large trials and real life cohort studies have indicated that below a definite BP value renal protection seems to plateau and too low levels may even be associated with a paradoxical increase in renal morbidity, thus reviving the debate about the so called BP -renal function J-curve relationship. Existing evidence supports a systolic target around 130 mm Hg to combine both renal and CV protection and possibly lower levels in the presence of overt proteinuria.

Keywords: J-curve relationship; RAAS-inhibition; albuminuria; chronic kidney disease; glomerular filtration rate; hypertension; target blood pressure.

©2018 Wiley Periodicals, Inc.

PubMed Disclaimer

Conflict of interest statement

The authors report conflict of interest to disclose.

References

    1. Coffman TM. The inextricable role of the kidney in hypertension. J Clin Investig. 2014;124(6):2341‐2347. - PMC - PubMed
    1. Kalaitzidis R, Li S, Wang C, Chen SC, McCullough PA, Bakris GL. Hypertension in early‐stage kidney disease: an update from the Kidney Early Evaluation Program (KEEP). Am J Kidney Dis. 2009;53(4 Suppl 4):S22‐S31. - PubMed
    1. Muntner P, Anderson A, Charleston J, et al. Hypertension awareness, treatment, and control in adults with CKD: results from the Chronic Renal Insufficiency Cohort (CRIC) Study. Am J Kidney Dis. 2010;55(3):441‐451. - PMC - PubMed
    1. Rossignol P, Massy ZA, Azizi M, et al. Cardiovascular and Renal Clinical Trialists (F‐CRIN INI‐CRCT) network. The double challenge of resistant hypertension and chronic kidney disease. Lancet. 2015;386(10003):1588‐1598. - PubMed
    1. Klag MJ, Whelton PK, Randall BL, Neaton JD, Brancati FL, Stamler J. End‐stage renal disease in African‐American and white men. 16‐year MRFIT findings. JAMA. 1997;277(16):1293‐1298. - PubMed

Publication types

MeSH terms

Substances

LinkOut - more resources